6. The μ-opioid receptor antagonist naltrexone is the most extensively studied treatment for alcohol dependence and should be considered as first-line treatment.
A. True
B. False
|
Home »
|
|
|
Psychiatric Times. Vol. 29 No. 9
MINE YOUR MIND
Alcohol Disorders: Practical Tips From New Research
By Mark J. Niciu Jr, MD, PhD and Ismene Petrakis, MD |
September 7, 2012
Dr Niciu is Clinical Research Fellow at the NIMH in Bethesda, Md; Dr Petrakis is Professor of Psychiatry at the Yale School of Medicine, New Haven, Conn, and Chief of Psychiatry at the VA Connecticut Healthcare System in West Haven, Conn. The authors report no conflicts of interest concerning the subject matter of this article.
6. The μ-opioid receptor antagonist naltrexone is the most extensively studied treatment for alcohol dependence and should be considered as first-line treatment. A. True B. False |
TOPIC INDEX
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners Courtney H. Lyder, ND, May 17, 2013 With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy. VWhat Physicians Can Learn from the Allscripts EHR Lawsuit Marisa Torrieri, May 16, 2013 Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse? Eight Ways ICD-9 Will Still Matter to Medical Practices Brenda Edwards, CPC, May 15, 2013 What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it. Seven Ways Technology Can Speed Up Patient Collections Cheyenne Brinson, May 15, 2013 Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right. Four Reasons Private Medical Practice is Becoming Extinct Carol Stryker, May 15, 2013 It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
CAREER CENTER
|